Dr. Katherine Palozola, PhDSenior Principal Investigator, Biology at Aro BiotherapeuticsSpeaker
Profile
Kate Palozola is a molecular biologist at Aro Biotherapeutics were she leads a team in discovering and characterizing siRNA therapies for novel gene targets. Prior to joining Aro, Kate trained at University of Pennsylvania in genetics, epigenetics, and gene regulation
Agenda Sessions
Interferon Gamma Enhances the Potency of Receptor Targeted siRNA Conjugates by Promoting Endosomal Escape
, 08:05View Session